1-benzhydryl-4-(3-phenylprop-1-enyl)piperazine
ADVERTISEMENT
- Molecular formula
- C25H28N2
- CAS Number
- 130249-79-1
- IUPAC Name
- 1-benzhydryl-4-(3-phenylprop-1-enyl)piperazine
- Molecular Weight
- 374.52g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1000g/cm3
- Synonyms
- Spectrum_001438
Identification
Interesting facts
Interesting Facts about 1-benzhydryl-4-(3-phenylprop-1-enyl)piperazine
1-benzhydryl-4-(3-phenylprop-1-enyl)piperazine is a fascinating compound that showcases the versatility of piperazine derivatives in medicinal chemistry. Here are some intriguing points to consider:
- Structure and Stability: The compound features a unique structure where the piperazine ring is substituted with a benzhydryl and a phenylprop-1-enyl group, contributing to its distinct properties.
- Medicinal Applications: Piperazine derivatives are known for their therapeutic potential. They have been explored for use in a variety of pharmacological applications, including but not limited to antidepressant and anxiolytic activities.
- Complex Synthesis: The synthesis of 1-benzhydryl-4-(3-phenylprop-1-enyl)piperazine may involve complex multistep reactions, often requiring advanced techniques in organic synthesis, which showcases the skill and creativity of chemists.
- Binding Affinity: Understanding the interactions of this compound with biological targets could help in elucidating its mechanism of action. Research into its binding affinity with specific receptors can uncover potential pathways for therapeutic use.
- Structure-Activity Relationship (SAR): Studying SAR for 1-benzhydryl-4-(3-phenylprop-1-enyl)piperazine could pave the way for the development of more effective analogs, tailoring modifications to enhance specific interactions or reduce adverse effects.
Overall, this compound not only represents a class of compounds that hold promise in drug development but also exemplifies the intricacies involved in synthetic organic chemistry. Understanding such compounds can lead to innovative solutions in the field of pharmaceuticals.